Lisa Trivison Beck
Corporate Officer/Principal at BRII BIOSCIENCES LIMITED
Profile
Lisa Trivison Beck is currently the Senior Vice President-Business Development at Brii Biosciences Ltd.
(China) since 2019.
Prior to this, she worked at Alexion Pharmaceuticals, Inc. as the Head-Transactions & Alliance Management from 2015 to 2018.
She also worked at GSK Plc for 24 years from 1991 to 2015, where she held the position of Director-Portfolio Management.
Ms. Beck completed her undergraduate degree from Vanderbilt University in 1984.
Lisa Trivison Beck active positions
| Companies | Position | Start |
|---|---|---|
| BRII BIOSCIENCES LIMITED | Corporate Officer/Principal | 17/12/2019 |
Former positions of Lisa Trivison Beck
| Companies | Position | End |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2018 |
| GSK PLC | Corporate Officer/Principal | 01/08/2015 |
Training of Lisa Trivison Beck
| Vanderbilt University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRII BIOSCIENCES LIMITED | Commercial Services |
| GSK PLC | Health Technology |
| Private companies | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Stock Market
- Insiders
- Lisa Trivison Beck